Correlation Between CytomX Therapeutics and Bolt Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and Bolt Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and Bolt Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and Bolt Biotherapeutics, you can compare the effects of market volatilities on CytomX Therapeutics and Bolt Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of Bolt Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and Bolt Biotherapeutics.
Diversification Opportunities for CytomX Therapeutics and Bolt Biotherapeutics
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between CytomX and Bolt is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and Bolt Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bolt Biotherapeutics and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with Bolt Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bolt Biotherapeutics has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and Bolt Biotherapeutics go up and down completely randomly.
Pair Corralation between CytomX Therapeutics and Bolt Biotherapeutics
Given the investment horizon of 90 days CytomX Therapeutics is expected to under-perform the Bolt Biotherapeutics. In addition to that, CytomX Therapeutics is 1.75 times more volatile than Bolt Biotherapeutics. It trades about -0.11 of its total potential returns per unit of risk. Bolt Biotherapeutics is currently generating about -0.08 per unit of volatility. If you would invest 76.00 in Bolt Biotherapeutics on August 28, 2024 and sell it today you would lose (16.00) from holding Bolt Biotherapeutics or give up 21.05% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
CytomX Therapeutics vs. Bolt Biotherapeutics
Performance |
| Timeline |
| CytomX Therapeutics |
| Bolt Biotherapeutics |
CytomX Therapeutics and Bolt Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CytomX Therapeutics and Bolt Biotherapeutics
The main advantage of trading using opposite CytomX Therapeutics and Bolt Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, Bolt Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bolt Biotherapeutics will offset losses from the drop in Bolt Biotherapeutics' long position.| CytomX Therapeutics vs. Eliem Therapeutics | CytomX Therapeutics vs. Scpharmaceuticals | CytomX Therapeutics vs. Milestone Pharmaceuticals | CytomX Therapeutics vs. Seres Therapeutics |
| Bolt Biotherapeutics vs. Eliem Therapeutics | Bolt Biotherapeutics vs. Scpharmaceuticals | Bolt Biotherapeutics vs. Milestone Pharmaceuticals | Bolt Biotherapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |